Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Pfizer Inc. (NYSE:PFE) is scheduled to release its financial results for the second quarter, before the opening bell on Tuesday.
輝瑞公司（紐交所：PFE）定於週二開盤前公佈其第二季度業績。
Analysts expect the New York-based company to report quarterly earnings at 46 cents per share, down from 67 cents per share in the year-ago period. Pfizer expects to post revenue of $13.02 billion, compared to $12.73 billion a year earlier, according to data from Benzinga Pro.
據Benzinga Pro的數據顯示，分析師預計這家總部位於紐約的公司將報告每股46美分的季度收益，低於去年同期的每股67美分。輝瑞公司預計營業收入爲130.2億美元，而去年同期爲127.3億美元。
On July 25, Pfizer announced that the European Commission approved a conditional marketing authorization for DURVEQTIX, a gene therapy for severe and moderately severe hemophilia B in adults whom meet certain criteria.
7月25日，輝瑞宣佈，歐洲委員會批准了DUR-VEQTTM的有條件的市場授權，該基因治療用於符合某些標準的成年嚴重和中度嚴重的血友病B患者。
Pfizer shares fell 0.2% to close at $30.72 on Monday.
週一，輝瑞股價下跌0.2％，收於30.72美元。
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Benzinga的讀者可以在分析師股票評級頁面上獲取最新的分析師評級。讀者可以按股票代號、公司名稱、分析師公司、評級變化或其他變量排序。
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
讓我們來看看Benzinga最準確的分析師是如何評價公司的。
- Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $45 on July 10. This analyst has an accuracy rate of 69%.
- Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and raised the price target from $28 to $29 on May 2. This analyst has an accuracy rate of 71%.
- BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and boosted the price target from $33 to $36 on May 2. This analyst has an accuracy rate of 71%.
- Argus Research analyst David Toung downgraded the stock from Buy to Hold on March 22. This analyst has an accuracy rate of 68%.
- Guggenheim analyst Vamil Divan initiated coverage on the stock with a Buy rating and a price target of $36 on Feb. 23. This analyst has an accuracy rate of 76%.
- Cantor Fitzgerald的分析師Louise Chen在7月10日重申了對該股票的增持評級，目標價格爲45美元。該分析師的準確率爲69％。
- 摩根士丹利的分析師Terence Flynn於5月2日維持了等權重的評級，並將目標價格從28美元上調至29美元。該分析師的準確率爲71％。
- BMO Capital的分析師Evan David Seigerman於5月2日重申跑贏大盤的評級，並將目標價格從33美元上調至36美元。該分析師的準確率爲71％。
- 雅運股份的分析師大衛·湯（David Toung）於3月22日將股票評級從買入下調至持有。該分析師的準確率爲68%。
- 古根海姆的分析師Vamil Divan於2月23日開始對該股票進行覆蓋，評級爲買入，目標價格爲36美元。該分析師的準確率爲76％。
Read This Next:
閱讀以下內容：
- More Than $4M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying
- 投資超過400萬美元的人賭appian？看看這3支股票內部人士正在購買